Loading clinical trials...
Loading clinical trials...
Psilocybin and Depression - Assessing the Long-term Effects of a Single Administration of Psilocybin on the Psychiatric Symptoms and Brain Activity of Patients With Severe Depression
Conditions
Interventions
Psilocybin
Ketamine (Ketalar)
Start Date
September 1, 2018
Primary Completion Date
January 1, 2020
Completion Date
September 1, 2021
Last Updated
December 21, 2017
NCT04618250
NCT03837340
Lead Sponsor
University of Helsinki
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions